文献速递胸部肿瘤

I期非小细胞肺癌部分实性或实性病灶的预后因素差异

Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
PubMed 文献 · J Thorac Oncol · 2019-08-19

研究回顾性分析2010例完全切除的病理I期浸润性非小细胞肺癌患者,按实性成分占比分为纯磨玻璃、部分实性和实性三组。多因素分析显示无磨玻璃成分是更差无复发生存期的强独立危险因素,且部分实性组脏层胸膜侵犯无预后价值,实性组腺癌亚型无预后价值。

要点

  • 无磨玻璃成分是I期浸润性非小细胞肺癌更差无复发生存期的强独立危险因素。
  • 部分实性组中脏层胸膜侵犯不能预测无复发生存期。
  • 实性组中腺癌亚型不是无复发生存期的预后因素。

核心结论

  • 磨玻璃成分的存在是病理I期浸润性非小细胞肺癌患者的强预测因素。
  • 部分实性组和实性组的风险因素不同。
  • 部分实性组中脏层胸膜侵犯无预后价值,实性组中腺癌亚型无预后价值。

研究设计与样本

  • 回顾性分析2010例完全切除的病理I期浸润性非小细胞肺癌患者,按第8版TNM分类。
  • 根据实性成分与肿瘤大小比值分为纯磨玻璃组、部分实性组和实性组。
  • 采用Cox多因素比例风险分析识别各组独立预后因素。

主要发现

  • 2010例患者中,纯磨玻璃组146例(7.3%),部分实性组732例(36.4%),实性组1132例(56.3%)。
  • Cox多因素分析显示无磨玻璃成分是更差无复发生存期的强独立危险因素(p < 0.001)。
  • 纯磨玻璃组尽管为浸润性分期,未观察到复发。
  • 部分实性组中脏层胸膜侵犯不能预测无复发生存期(总体p = 0.514;肿瘤大小≤1 cm p = 0.664;>1至2 cm p = 0.456;>2至3 cm p = 0.900;>3至4 cm p = 0.397)。
  • 实性组中腺癌亚型不是无复发生存期的预后因素(总体p = 0.162;肿瘤大小≤2 cm p = 0.092;>2至3 cm p = 0.330;>3至4 cm p = 0.885)。

临床怎么用

  • 在病理I期浸润性非小细胞肺癌中,应关注磨玻璃成分的存在以评估复发风险。
  • 对部分实性病灶,脏层胸膜侵犯不应作为复发风险分层依据。
  • 对实性病灶,腺癌亚型不应作为复发风险分层依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Recent studies have indicated that the presence of ground-glass opacity (GGO) components is associated with favorable survival. The purpose of this study was to reveal the prognostic value of GGO components and differences in prognostic factors for part-solid and solid lesions in invasive stage I NSCLC. METHODS: The cases of 2010 patients with completely resected invasive pathological stage I NSCLC were reviewed according to the eighth edition of the TNM classification. Patients were categorized into the pure-GGO, part-solid, and solid groups based on consolidation-to-tumor ratio. Cox multivariate proportional hazard analyses were conducted to identify independent prognostic factors in each group. RESULTS: Of the 2010 patients, 146 (7.3%) were in the pure-GGO group, 732 (36.4%) were in the part-solid group, and 1132 (56.3%) were in the solid group. Cox multivariate analyses revealed that GGO absence was a strong independent risk factor for worse recurrence-free survival (p < 0.001). For the pure-GGO group, there was no recurrence in spite of the invasive stage. For the part-solid group, visceral pleural invasion could not predict recurrence-free survival in general (p = 0.514) or in each tumor size group (for tumors size ≤1 cm, p = 0.664; for tumors size >1 to 2 cm, p = 0.456; for tumors size >2 to 3 cm, p = 0.900; and for tumors size >3 to 4 cm, p = 0.397). For the solid group, adenocarcinoma subtype was not a prognostic factor for recurrence-free survival in general (p = 0.162) or in each tumor size group (for tumors size ≤ 2 cm, p = 0.092; for tumors size >2 to 3 cm, p = 0.330; and for tumors size >3 to 4 cm, p = 0.885). CONCLUSIONS: The presence of GGO components was a strong predictor in patients with invasive pathological stage I NSCLC. Risk factors were distinct in the part-solid and solid groups. There was no prognostic value of visceral pleural invasion in the part-solid group. Adenocarcinoma subtype did not have prognostic value in the solid group.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Fu F, Zhang Y, Wen Z, et al. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions. J Thorac Oncol. 2019. PMID: 31437531. doi:10.1016/j.jtho.2019.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。